المنشورات

FOI.ICB-2526/120: NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro)

FOI.ICB-2526/109: 2025/26 Joint Capital Resource Use Plan

FOI.ICB-2526/108: Staff with Criminal Convictions

FOI.ICB-2526/029: Children and Adults ADHD Assessments

FOI.ICB-2526/117: ADHD Staff Training

FOI.ICB-2526/080: Evaluation of Operation Topaz

FOI.ICB-2526/094: Cath Labs

FOI.ICB-2526/111: Neighbourhood Teams

FOI.ICB-2526/098: Personal Health Budgets (PHBs)

FOI.ICB-2526/090: Fraud Incidents Relating to Personal Health Budgets (PHBs)

FOI.ICB-2526/101: Sleep Medication and or Sleep Treatments

FOI.ICB-2526/105: Medicines Management Software Solutions